Bristol-Myers Squibb
BMY
2,368 hedge funds and large institutions have $102B invested in Bristol-Myers Squibb in 2021 Q1 according to their latest regulatory filings, with 158 funds opening new positions, 995 increasing their positions, 939 reducing their positions, and 119 closing their positions.
33% more first-time investments, than exits
New positions opened: 158 | Existing positions closed: 119
11% more call options, than puts
Call options by funds: $1.15B | Put options by funds: $1.04B
6% more repeat investments, than reductions
Existing positions increased: 995 | Existing positions reduced: 939
0% more funds holding
Funds holding: 2,359 → 2,368 (+9)
0.69% less ownership
Funds ownership: 73.69% → 73% (-0.69%)
1% less capital invested
Capital invested by funds: $104B → $102B (-$1.54B)
10% less funds holding in top 10
Funds holding in top 10: 78 → 70 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$322M |
| 2 |
Goldman Sachs
New York
|
+$254M |
| 3 |
BlackRock
New York
|
+$245M |
| 4 |
JP Morgan Chase
New York
|
+$230M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$167M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$716M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$470M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$384M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$279M |
| 5 |
Bank of New York Mellon
New York
|
-$259M |
BMY Hedge Fund Activity: Q1 2021 in Review
2,368 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q1 2021, worth a combined $102B — down 1.5% from $104B a quarter earlier.
Buyers outnumbered sellers: 158 funds opened new BMY positions and 119 closed out — a net gain of 39 holders — while 995 added to existing stakes and 939 trimmed.
The largest buyer was Franklin Resources, adding an estimated $322M. The largest seller was Renaissance Technologies, cutting an estimated $716M.
- 2,368 institutional investors held Bristol-Myers Squibb (BMY) as of Q1 2021, up from 2,359 in Q4 2020.
- Funds reported $102B of Bristol-Myers Squibb stock for Q1 2021, down 1.5% quarter-over-quarter.
- 158 funds opened new Bristol-Myers Squibb positions in Q1 2021 and 119 closed out, a net change of +39 holders.
- The largest Bristol-Myers Squibb buyer in Q1 2021 was Franklin Resources, an estimated $322M added.
- The largest Bristol-Myers Squibb seller in Q1 2021 was Renaissance Technologies, an estimated $716M sold.
Based on aggregated 13F filings for Q1 2021.